Scholarlink

<p>Introduction: Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive disorder caused by pathogenic variants in <i>CYP27A1</i>, leading to cholestanol accumulation and progressive neurological dysfunction. Neurofilament light chain (NfL) is a biomarker of neuroaxonal injury in several hereditary ataxias, but its role in CTX has not been investigated. We aimed to determine whether serum NfL is elevated in CTX and whether it correlates with clinical severity. Methods: Five genetically confirmed CTX patients and five age-, sex-, and body mass index–matched healthy controls were evaluated. Clinical severity was assessed using the Scale for the Assessment and Rating of Ataxia (SARA). Serum NfL concentrations were measured using single-molecule array technology. Group comparisons were performed using the Mann–Whitney U test, and associations were assessed using Spearman’s correlation coefficient. Results: Serum NfL levels were significantly higher in CTX patients than in controls (median 14.63 pg/mL [interquartile range 5.10–18.17] vs. 2.90 pg/mL [2.52–3.56]; p = 0.008). Within the CTX group, NfL levels showed a strong positive correlation with SARA scores (Spearman's ρ = 0.90, p = 0.037), indicating higher NfL levels in patients with greater neurological impairment. Conclusion: Serum NfL is elevated in CTX and correlates with ataxia severity, supporting its potential relevance as a marker of neuroaxonal injury in this disorder. Larger longitudinal studies are needed to confirm these preliminary findings and clarify the role of NfL in disease monitoring.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Serum Neurofilament Light Levels in Patients with Cerebrotendinous Xanthomatosis: a Pilot Study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月17日

查看全文
  • Antonio Edvan Camelo-Filho,
  • Pedro Lucas Grangeiro Sá Barreto Lima,
  • Rodrigo Fagundes da Rosa,
  • Oliver R Miyajima,
  • Matheus Henrique Brustolim Marcucci,
  • Stephanie Suzanne de Oliveira Scott,
  • Luis Edmundo Teixeira de Arruda Furtado,
  • Annyta F Frota,
  • Michelle V R Soares,
  • Danielle S Macedo,
  • André Pessoa,
  • Paulo R Nóbrega,
  • Pedro Braga-Neto

摘要

Introduction: Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive disorder caused by pathogenic variants in CYP27A1, leading to cholestanol accumulation and progressive neurological dysfunction. Neurofilament light chain (NfL) is a biomarker of neuroaxonal injury in several hereditary ataxias, but its role in CTX has not been investigated. We aimed to determine whether serum NfL is elevated in CTX and whether it correlates with clinical severity. Methods: Five genetically confirmed CTX patients and five age-, sex-, and body mass index–matched healthy controls were evaluated. Clinical severity was assessed using the Scale for the Assessment and Rating of Ataxia (SARA). Serum NfL concentrations were measured using single-molecule array technology. Group comparisons were performed using the Mann–Whitney U test, and associations were assessed using Spearman’s correlation coefficient. Results: Serum NfL levels were significantly higher in CTX patients than in controls (median 14.63 pg/mL [interquartile range 5.10–18.17] vs. 2.90 pg/mL [2.52–3.56]; p = 0.008). Within the CTX group, NfL levels showed a strong positive correlation with SARA scores (Spearman's ρ = 0.90, p = 0.037), indicating higher NfL levels in patients with greater neurological impairment. Conclusion: Serum NfL is elevated in CTX and correlates with ataxia severity, supporting its potential relevance as a marker of neuroaxonal injury in this disorder. Larger longitudinal studies are needed to confirm these preliminary findings and clarify the role of NfL in disease monitoring.